During the holidays, I received the letter below from Dr. Peter Eisenberg, Medical Director at California Cancer Care, an oncology practice in Northern California. A member of The Century Foundation’s Working Group on Medicare Reform. Eisenberg is a very experienced, and successful oncologist, who has served on the board of the American Society of Clinical Oncology and the Association of Northern California Oncologists.
One of the things I admire about Eisenberg is that he pulls no punches. In the extraordinarily candid letter below he criticizes a health care system that pays physicians fee-for-service for “doing more” in the form of ever more aggressive treatments.
Sometimes they are effective. Often they are not. Meanwhile, the same system pays little or nothing for what some call “thinking medicine”—consulting with other doctors, counseling patients, giving them choices, and offering services that recognize patients as human beings.
“Medicare pays just $69 for a 15 minute office visit with an established patient; $103 for 25 minutes and $138 for a 40-minute visit,” Eisenberg observes. “As you might imagine” he adds, “even if our doctors saw back-to-back patients 10 hours a day, we would not generate the kind of dollars from evaluation and management fees on our Medicare population to pay more than a fraction of our costs, including rent, salaries for our large staff and our new electronic medical records.
But Eisenberg does not just blame “the system.” He recognizes that all of us—doctors and patients, not to mention insurers and Pharma—help perpetuate a system that, too often, values the most expensive and aggressive treatments over patient “care.” In our society, patients play a role; we expect that everything can and should be cured. Or, as Eisenberg put it: “we expect that we can smoke 2 packs a day for 30 years and the doc will ‘fix it.’”
In the eye-opening final section of this letter, Eisenberg talks, very specifically about the “financial inducements” that lead many oncologists to decide which drugs to use—and how frequently to administer them—based, not on what is best for the patient, but on what will maximize the physician’s reimbursement.
Continue reading →